Pharvaris
Justin Bush has held various leadership roles in the commercial sector, specifically within the rare disease and biologics field. With a strong background in marketing and brand management, Justin has successfully led teams at companies such as Takeda, Biogen, and Shire. With an educational background from Cornell University and Boston University, including an MBA in Health Sector Management & Marketing, Justin brings a wealth of knowledge and experience to their current role as Global Commercial Lead at Pharvaris.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.